Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sotera Health (SHC) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to 10.02%.

  • Sotera Health's EBITDA Margin fell 32200.0% to 10.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.74%, marking a year-over-year decrease of 6400.0%. This contributed to the annual value of 6.47% for FY2024, which is 127000.0% down from last year.
  • Latest data reveals that Sotera Health reported EBITDA Margin of 10.02% as of Q3 2025, which was down 32200.0% from 30.28% recorded in Q2 2025.
  • In the past 5 years, Sotera Health's EBITDA Margin ranged from a high of 30.28% in Q2 2025 and a low of 104.29% during Q4 2022
  • Over the past 5 years, Sotera Health's median EBITDA Margin value was 2.18% (recorded in 2025), while the average stood at 0.5%.
  • Per our database at Business Quant, Sotera Health's EBITDA Margin tumbled by -1284900bps in 2022 and then skyrocketed by 1236700bps in 2023.
  • Over the past 5 years, Sotera Health's EBITDA Margin (Quarter) stood at 24.2% in 2021, then tumbled by -531bps to 104.29% in 2022, then skyrocketed by 119bps to 19.38% in 2023, then crashed by -227bps to 24.57% in 2024, then skyrocketed by 141bps to 10.02% in 2025.
  • Its last three reported values are 10.02% in Q3 2025, 30.28% for Q2 2025, and 2.18% during Q1 2025.